Management of hyperkalemia in patients with kidney disease: a position paper endorsed by the Italian Society of Nephrology

Hyperkalemia (HK) is the most common electrolyte disturbance observed in patients with kidney disease, particularly in those in whom diabetes and heart failure are present or are on treatment with renin–angiotensin–aldosterone system inhibitors (RAASIs). HK is recognised as a major risk of potential...

Descripción completa

Detalles Bibliográficos
Autores principales: Bianchi, Stefano, Aucella, Filippo, De Nicola, Luca, Genovesi, Simonetta, Paoletti, Ernesto, Regolisti, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Position papers and Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588653/
https://www.ncbi.nlm.nih.gov/pubmed/31119681
http://dx.doi.org/10.1007/s40620-019-00617-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588653/
https://www.ncbi.nlm.nih.gov/pubmed/31119681
http://dx.doi.org/10.1007/s40620-019-00617-y

Ejemplares similares